When transitioning towards value-based oncology, large employers should look to value-based models that have worked for other conditions, said Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition. These successful payment models include patient-centered medical homes, bundled payments, and accountable care organizations.
When transitioning towards value-based oncology, large employers should look to value-based models that have worked for other conditions, said Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition. These successful payment models include patient-centered medical homes, bundled payments, and accountable care organizations (ACOs).
Transcript (slightly modified)
What value-based reimbursement models have worked well for large employer groups?
For many years, employers have had a value-based benefit design—at least the large self-funded employers have—and I’ve seen a lot of success in that, but it hasn’t been in the oncology space. So other payment mechanisms, other care models that have worked: the patient-centered medical home concept for care has been something that the employers have really embraced. They have eliminated the co-pays and the deductibles if their plan members access care at a patient-centered medical home. The early indications data-wise are that the patients who have chronic diseases are better managed, so the costs have dropped somewhat. We’re seeing fewer emergency department visits, fewer hospitalizations, so that model has worked very, very well.
They’re just now getting into bundled payments; it had started with hips and knee replacements primarily. A lot of value there because they are the best providers and the cost is known on the front end, and they’ve figured out how to steer patients that way and that’s worked really well. Starting to look at labor and delivery as a bundled payment, so there may be some opportunities there. Obviously, cancer is a lot more complex than some of these other 1-time events, if you will.
And ACOs, it’s taken longer than I thought for the employers to work with the ACOs in Florida, but starting January 1st, 2017, we have quite a few of our employers who have contracted with the hospital-based ACOs, so we’ll keep our eyes on how that plays out.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More